Join to view full profile
1100 Fairview Avenue N, S3-204P.O. Box 19024Seattle, WA 98109
Dr. Warren is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Edus H. Warren III, MD, PhD is an oncology specialist based in Seattle, WA. He received his MD from Harvard Medical School and his PhD from Harvard University, completed an internship and residency in Internal Medicine at Massachusetts General Hospital, and completed a fellowship in Medical Oncology at the University of Washington and Fred Hutchinson Cancer Center. He has expertise in the management of hematologic malignancies, particularly with immunotherapeutic approaches such as allogeneic hematopoietic cell transplantation and CAR T-cell therapy. He runs a research lab at the Fred Hutchinson Cancer Center that is focused on the development of novel strategies using T lymphocytes to treat cancer.
Education & Training
University of WashingtonFellowship, Medical Oncology, 1993 - 1996
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1992 - 1993
Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 1991 - 1992
Harvard Medical SchoolClass of 1991
Certifications & Licensure
WA State Medical License 1993 - 2027
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World Experience.Ivan J Huang, Grace T Baek, Jonathan Cohen, Sirin Khajaviyan, Stephanie Louie
JCO Oncology Practice. 2025-05-01 - 2 citationsT-cells specific for KSHV and HIV migrate to Kaposi sarcoma tumors and persist over time.Shashidhar Ravishankar, Andrea M H Towlerton, Iyabode L Tiamiyu, Peter Mooka, Janet Nankoma
Biorxiv. 2025-02-15 - 14 citationsGeographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responses.Edward L Briercheck, Shashidhar Ravishankar, Elshafa Hassan Ahmed, César Camilo Carías Alvarado, Juan Carlos Barrios Menéndez
Blood Advances. 2024-07-23
Press Mentions
A Young Scientist's New Directions in Colorectal Cancer ResearchAugust 13th, 2010
Liquid Biopsies Cut EBV Burkitt Lymphoma Time to DiagnosisMay 19th, 2026
Grant Support
- Cancer Genomics and Genomic Data Science for East AfricaFRED HUTCHINSON CANCER CENTER2022–2028
- Comprehensive Characterization of the T-cell Response to KSHV to Enable Specific Immune TherapyFRED HUTCHINSON CANCER CENTER2025–2027
- HIV persistence and treatment response in Kaposi sarcomaFRED HUTCHINSON CANCER CENTER2025–2027
- Dissecting the Kaposi Sarcoma Tumor Microenvironment at the Single Cell LevelFRED HUTCHINSON CANCER CENTER2019–2025
- Building independent research leaders in HIV-associated malignancies in UgandaFRED HUTCHINSON CANCER CENTER2014–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
